Hemostasis Today
NewsFeed
Headlines Hematology Health Medicine VTE ASH Plasma Donation
August, 2026
August 2026
M T W T F S S
 12
3456789
10111213141516
17181920212223
24252627282930
31  

Behnood Bikdeli

Tobias Tritschler: Evaluating Timing, Translation and Preparedness in COVID-19 Anticoagulation Management
Jul 30, 2026, 18:11 | Science
Tobias Tritschler: Evaluating Timing, Translation and Preparedness in COVID-19 Anticoagulation Management
Tobias Tritschler, Leitender Arzt at Insel Gruppe, shared a post on LinkedIn about a recent article…
Heghine Khachatryan: Pregnancy, Thrombosis, and Aspirin - Who Really Needs Prophylaxis?
Jun 13, 2026, 14:36 | Science
Heghine Khachatryan: Pregnancy, Thrombosis, and Aspirin - Who Really Needs Prophylaxis?
Heghine Khachatryan, Editor-in-Chief of Hemostasis Today, Head of Hemophilia and Thrombosis Center at Yeolyan Hematology…
Mattia Galli: Is Clopidogrel Superior to Aspirin for Secondary Prevention in CCS?
May 28, 2026, 20:41 | Science
Mattia Galli: Is Clopidogrel Superior to Aspirin for Secondary Prevention in CCS?
Mattia Galli, Assistant Professor at Sapienza University of Rome, Associate Editor of European Heart Journal,…
Dirk Sibbing: Ethnicity and Antiplatelet Therapy Outcomes in CCS
May 22, 2026, 08:45 | Science
Dirk Sibbing: Ethnicity and Antiplatelet Therapy Outcomes in CCS
Dirk Sibbing, Cardiologist and Angiologist at Lauterbacher Mill Private Clinic and LMU Munich, shared a…
Claudio Laudani: A Striking Geographic Heterogeneity in Aspirin and Clopidogrel Comparison for MACE Prevention
May 21, 2026, 02:25 | Science
Claudio Laudani: A Striking Geographic Heterogeneity in Aspirin and Clopidogrel Comparison for MACE Prevention
Claudio Laudani, Former Postdoctoral Researcher at UF Health Jacksonville, shared a post on LinkedIn about…
Behnood Bikdeli: A Wonderful Experience at the International Symposium on Thrombosis and Vessels
May 18, 2026, 13:23 | Voices
Behnood Bikdeli: A Wonderful Experience at the International Symposium on Thrombosis and Vessels
Behnood Bikdeli, Cardiologist and Vascular Medicine Specialist at Brigham and Women’s Hospital and Harvard Medical…
Understanding Cardiovascular Thrombosis and Myocarditis - UT Southwestern Heart and Vascular
May 16, 2026, 11:17 | Science
Understanding Cardiovascular Thrombosis and Myocarditis - UT Southwestern Heart and Vascular
UT Southwestern Heart and Vascular shared a post on LinkedIn about recent articles, published in…
Shashank Joshi: Antiphospholipid Antibodies and Risk of Thrombotic Cardiovascular Events
May 12, 2026, 13:49 | Science
Shashank Joshi: Antiphospholipid Antibodies and Risk of Thrombotic Cardiovascular Events
Shashank Joshi, Endocrine Physician at Lilavati Hospital And Research Centre, shared a post on LinkedIn…
Behnood Bikdeli: A Landmark JACC Journals Issue on Pulmonary Embolism
Apr 29, 2026, 15:29 | Voices
Behnood Bikdeli: A Landmark JACC Journals Issue on Pulmonary Embolism
Behnood Bikdeli, Cardiologist and Vascular Medicine Specialist at Brigham and Women’s Hospital and Harvard Medical…
Gregory Piazza: When Antibodies Trigger Thrombosis
Apr 6, 2026, 13:35 | Insight
Gregory Piazza: When Antibodies Trigger Thrombosis
Gregory Piazza, Director of the Vascular Medicine Section at Brigham and Women’s Hospital, shared a…
Antonio Pineda Guerrero: Elevated Lp(a) Raises VTE Risk But Only in the Right Hormonal Context
Apr 1, 2026, 17:21 | Science
Antonio Pineda Guerrero: Elevated Lp(a) Raises VTE Risk But Only in the Right Hormonal Context
Antonio Pineda Guerrero, Research Trainee at INIT-UJI, shared a post on LinkedIn about a recent…
Gregory Piazza: Proud Moment for Thrombosis Research Group at ACC.26
Apr 1, 2026, 15:18 | Science
Gregory Piazza: Proud Moment for Thrombosis Research Group at ACC.26
Gregory Piazza, Director of the Vascular Medicine Section at Brigham and Women’s Hospital, shared a…
Maria Angelica Pabon: LPA Relation to VTE Appears To Be Hormone-Dependent
Mar 30, 2026, 17:25 | Science
Maria Angelica Pabon: LPA Relation to VTE Appears To Be Hormone-Dependent
Maria Angelica Pabon, Cardiologist at Brigham and Women's Hospital, shared on LinkedIn about a recent article…
Giuseppe Lippi: New Insights Into Antiphospholipid Antibodies and Cardiovascular Thrombosis
Mar 13, 2026, 16:52 | Voices
Giuseppe Lippi: New Insights Into Antiphospholipid Antibodies and Cardiovascular Thrombosis
Giuseppe Lippi, Professor at University of Verona, Dean at Faculty of Medicine and Surgery, shared…
Alfonso Tafur: The Data Behind Cancer-Associated Thrombosis
Mar 13, 2026, 11:36 | Voices
Alfonso Tafur: The Data Behind Cancer-Associated Thrombosis
Alfonso Tafur, Vascular Medicine Fellowship Program Director at the University of Chicago, Director of Vascular…
Mattia Galli: A Privilege to Collaborate on Such a Complex Topic as Cardio-Rheumatology
Mar 11, 2026, 17:23 | Science
Mattia Galli: A Privilege to Collaborate on Such a Complex Topic as Cardio-Rheumatology
Mattia Galli, Assistant Professor at Sapienza University of Rome, Associate Editor of European Heart Journal,…
Abdulrahman Katib: Extended Low-Dose DOAC May Reduce VTE Recurrence
Feb 1, 2026, 13:23 | Science
Abdulrahman Katib: Extended Low-Dose DOAC May Reduce VTE Recurrence
Abdulrahman Katib, Internal Medicine and Adult Thrombosis Consultant at King Faisal Specialist Hospital and Research…
Jamilla Goedegebuur and Colleagues on VTE Management in Case of PAD
Jan 22, 2026, 11:41 | Science
Jamilla Goedegebuur and Colleagues on VTE Management in Case of PAD
RPTH Journal shared on LinkedIn: ''How to manage VTE in patients with peripheral arterial disease…
We Analyzed Data From the Start of the COVID-19 Pandemic to 2024 - What Did We find?
Jan 4, 2026, 14:46 | Insight
We Analyzed Data From the Start of the COVID-19 Pandemic to 2024 - What Did We find?
Gregory Piazza, Director of the Vascular Medicine Section at Brigham and Women’s Hospital, shared on…
Gregory Piazza on Identifying Thromboprophylaxis and Aspirin Use in Pregnancy
Nov 28, 2025, 16:45 | Science
Gregory Piazza on Identifying Thromboprophylaxis and Aspirin Use in Pregnancy
Gregory Piazza, Director of the Vascular Medicine Section at Brigham and Women’s Hospital, shared on…
Apixaban for Extended Treatment of Provoked VTE: New NEJM Study Challenges Treatment Paradigm
Nov 26, 2025, 04:51 | Science
Apixaban for Extended Treatment of Provoked VTE: New NEJM Study Challenges Treatment Paradigm
Emma P. with Clinical Research Professionals shared a post on LinkedIn: "Apixaban for Extended Treatment…
Pall T. Onundarson: This JACC Review is Highly Biased in Favor of DOAC Drugs
Nov 25, 2025, 09:09 | Voices
Pall T. Onundarson: This JACC Review is Highly Biased in Favor of DOAC Drugs
Pall T. Onundarson, Professor Emeritus at Landspitali University Hospital, shared a post on LinkedIn: "Bruno, is…
Bruno Pougault on the Limitations of DOACs in High-Risk Conditions
Nov 22, 2025, 16:17 | Science
Bruno Pougault on the Limitations of DOACs in High-Risk Conditions
Bruno Pougault, Global Marketing Hemostasis Product Manager at HORIBA, shared on LinkedIn: ''DOACs may not…
Gregory Piazza on CORONA-VTE Network Analysis
Oct 28, 2025, 13:09 | Science
Gregory Piazza on CORONA-VTE Network Analysis
Gregory Piazza, Director of the Vascular Medicine Section at Brigham and Women’s Hospital, shared on…
Hatim Lokhandwala: Landmark HI-PRO Trial Redefines VTE Treatment Guidelines
Oct 12, 2025, 10:14 | Science
Hatim Lokhandwala: Landmark HI-PRO Trial Redefines VTE Treatment Guidelines
Hatim Lokhandwala, Clinical Research Coordinator, Hope & Healing Cancer Services LLC, shared a post on LinkedIn:…
Superficial Vein Thrombosis: Gregory Piazza Leads JAMA Review Addressing An Underrecognized Challenge
Oct 9, 2025, 13:08 | Science
Superficial Vein Thrombosis: Gregory Piazza Leads JAMA Review Addressing An Underrecognized Challenge
  Gregory Piazza, Director of the Vascular Medicine Section at Brigham and Women’s Hospital, posted…
Sina Rashedi on Fibrinolytic Therapies in Different Thromboembolic Diseases
Oct 2, 2025, 14:10 | Science
Sina Rashedi on Fibrinolytic Therapies in Different Thromboembolic Diseases
Sina Rashedi, Postdoctoral Research Fellow at Brigham and Women’s Hospital, Harvard Medical School, reposted from…
HI-PRO Trial: Apixaban for Long-Term Prevention of Recurrent VTE
Sep 30, 2025, 06:42 | Science
HI-PRO Trial: Apixaban for Long-Term Prevention of Recurrent VTE
The New England Journal of Medicine (NEJM) has shared a post on X: “In patients with…
Manuel Monreal: Machine Learning Identifies PE Patients at Risk for CTEPH
Sep 27, 2025, 12:54 | Science
Manuel Monreal: Machine Learning Identifies PE Patients at Risk for CTEPH
Manuel Monreal, coordinator of the RIETE registry, posted on X: “Identifying PE patients at increased…
Darsiya Krishnathasan: Superficial Vein Thrombosis Review in JAMA Provides Practical Guidance
Sep 26, 2025, 14:24 | Insight
Darsiya Krishnathasan: Superficial Vein Thrombosis Review in JAMA Provides Practical Guidance
Darsiya Krishnathasan, Research Assistant at Brigham and Women's Hospital, shared a post on LinkedIn: "Superficial…
Jan Sloves Applaudes Gregory Piazza and Colleagues: Excellent Review Paper on SVT
Sep 25, 2025, 17:14 | Science
Jan Sloves Applaudes Gregory Piazza and Colleagues: Excellent Review Paper on SVT
Jan Sloves, President and Consultant at Vascular Imaging Professionals LLC, shared on LinkedIn: ''My Top…
Apixaban: Low-Dose Long-Term Use After Provoked VTE Shows Benefits
Sep 21, 2025, 16:25 | Science
Apixaban: Low-Dose Long-Term Use After Provoked VTE Shows Benefits
Christopher Cannon, Editor in Chief, Harvard Health Publishing, shared a post on LinkedIn: "Low-dose Apixaban…
Behnood Bikdeli: JAMA Review on Epidemiology, Diagnosis, and Treatment of Superficial Vein Thrombosis
Sep 17, 2025, 10:12 | Science
Behnood Bikdeli: JAMA Review on Epidemiology, Diagnosis, and Treatment of Superficial Vein Thrombosis
Behnood Bikdeli, a cardiologist and vascular medicine specialist at Brigham and Women’s Hospital and Harvard…
Superficial Vein Thrombosis Management: John Fanikos Shares Latest Review
Sep 17, 2025, 08:16 | Insight
Superficial Vein Thrombosis Management: John Fanikos Shares Latest Review
John Fanikos, Director of Strategic Initiatives at North American Thrombosis Forum, shared a post on…
Gregory Piazza Presents HI-PRO Trial Results on VTE at ESC Congress
Sep 16, 2025, 11:25 | Science
Gregory Piazza Presents HI-PRO Trial Results on VTE at ESC Congress
Gregory Piazza, Director of the Vascular Medicine Section at Brigham and Women’s Hospital, posted on…
Gregory Piazza & Darsiya Krishnathasan: A Review on Superficial Vein Thrombosis
Sep 15, 2025, 13:44 | Science
Gregory Piazza & Darsiya Krishnathasan: A Review on Superficial Vein Thrombosis
Gregory Piazza, Director of the Vascular Medicine Section at Brigham and Women’s Hospital, shared on…
Gregory Piazza on The Link Between VTE and Atherothrombosis
Sep 10, 2025, 21:13 | Science
Gregory Piazza on The Link Between VTE and Atherothrombosis
Gregory Piazza, Director of the Vascular Medicine Section at Brigham and Women’s Hospital, shared on…
Is Lipoprotein(a) a Risk Factor for Blood Clots? Gregory Piazza and Team Publish Landmark Study
Sep 9, 2025, 08:03 | Science
Is Lipoprotein(a) a Risk Factor for Blood Clots? Gregory Piazza and Team Publish Landmark Study
  Gregory Piazza, Director of the Vascular Medicine Section at Brigham and Women’s Hospital, posted…
Extended Low-Dose Apixaban After Provoked VTE: Marc Carrier Spotlights Major NEJM Results
Aug 31, 2025, 07:23 | Science
Extended Low-Dose Apixaban After Provoked VTE: Marc Carrier Spotlights Major NEJM Results
  Marc Carrier, Professor at Ottawa Hospital Research Institute, has posted on X: ''New in…
RIETE Registry Data: Manuel Monreal on VTE vs. Bleeding Risks in Cancer Patients
Aug 31, 2025, 07:05 | Science
RIETE Registry Data: Manuel Monreal on VTE vs. Bleeding Risks in Cancer Patients
  Manuel Monreal, coordinator of the RIETE registry, posted on X: ''The risk of the…
Extended Low-Dose Apixaban Reduces Risk of Recurrent VTE: HI-PRO Trial Results
Aug 30, 2025, 14:43 | Science
Extended Low-Dose Apixaban Reduces Risk of Recurrent VTE: HI-PRO Trial Results
Sina Rashedi, Postdoctoral Research Fellow at Brigham and Women’s Hospital, Harvard Medical School, shared a…
Behnood Bikdeli Discusses VTE Litigation After Orthopedic Surgery in Thrombosis Research Editorial
Aug 30, 2025, 09:12 | Insight
Behnood Bikdeli Discusses VTE Litigation After Orthopedic Surgery in Thrombosis Research Editorial
  Behnood Bikdeli, a cardiologist and vascular medicine specialist at Brigham and Women’s Hospital and…
Behnood Bikdeli and Colleagues Summarize 2025 ACC/AHA Recommendations for Antiplatelet and Anticoagulant Therapy for Acute Coronary Syndrome
Aug 24, 2025, 08:51 | Insight
Behnood Bikdeli and Colleagues Summarize 2025 ACC/AHA Recommendations for Antiplatelet and Anticoagulant Therapy for Acute Coronary Syndrome
Behnood Bikdeli, a cardiologist and vascular medicine specialist at Brigham and Women’s Hospital and Harvard Medical…
Manuel Monreal: Cancer Site Influences VTE Outcomes
Aug 23, 2025, 08:27 | Science
Manuel Monreal: Cancer Site Influences VTE Outcomes
Manuel Monreal, coordinator of the RIETE registry, posted  on X: ”The impact of cancer site…
Antoine Bejjani on the Link Between Venous Thromboembolism (VTE) and Atherothrombosis
Aug 21, 2025, 15:12 | Insight
Antoine Bejjani on the Link Between Venous Thromboembolism (VTE) and Atherothrombosis
Antoine Bejjani, an Internal Medicine Resident and Postdoctoral Research Fellow at Brigham and Women's Hospital,…
Behnood Bikdeli on Comparative Effectiveness Research Examples in Thrombosis
Aug 12, 2025, 20:23 | Science
Behnood Bikdeli on Comparative Effectiveness Research Examples in Thrombosis
Behnood Bikdeli, a cardiologist and vascular medicine specialist at Brigham and Women’s Hospital and Harvard…
What's Hot in Clots – August 2025: Explore AF, PFO, STROKE, Antithrombotics and Cancer in One
Aug 10, 2025, 02:59 | Insight
What's Hot in Clots – August 2025: Explore AF, PFO, STROKE, Antithrombotics and Cancer in One
Vasculearn Network shared an inviting post on LinkedIn: ''Hope you’re soaking up summer and finding…
RPTH Journal: Rivaroxaban vs Warfarin in PE with RV Dysfunction
Aug 6, 2025, 12:52 | Insight
RPTH Journal: Rivaroxaban vs Warfarin in PE with RV Dysfunction
RPTH Journal shared a new study on LinkedIn: ''Do clinical outcomes differ between patients treated…
All: 48 Posts: 1 - 100
NewsFeed